Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered ...

Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...

FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the next to take the position after Donald Trump is elected president for the ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

FDA employees are reportedly eyeing exits amid talks of Robert F. Kennedy Jr. joining Trump's administration. Concerns extend ...